|
業務類別
|
Biotechnology |
|
業務概覽
|
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others. |
| 公司地址
| 75 Hayden Avenue, Lexington, MA, USA, 02421 |
| 電話號碼
| +1 857 259-5340 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.voyagertherapeutics.com |
| 員工數量
| 172 |
| Dr. Nathan Jorgensen, M.B.A.,PhD |
Chief Financial Officer and Principal Accounting Officer |
美元 228.00K |
09/03/2026 |
| Dr. Alfred W. Sandrock, Jr,M.D.,PhD |
Director, President and Chief Executive Officer |
美元 652.08K |
09/03/2026 |
| Ms. Jacquelyn Fahey Sandell, J.D. |
Chief Legal Officer |
-- |
23/04/2025 |
| Dr. Todd Carter, PhD |
Chief Scientific Officer |
-- |
23/04/2025 |
| Ms. Robin Swartz |
Chief Operating Officer |
-- |
23/04/2025 |
|
|
| Mr. James A. Geraghty |
Independent Director |
09/03/2026 |
| Mr. Michael J. Higgins |
Chairman of the Board |
09/03/2026 |
| Dr. Glenn F. Pierce, M.D.,PhD |
Independent Director |
09/03/2026 |
| Dr. Steven E. Hyman, M.D. |
Independent Director |
09/03/2026 |
| Ms. Nancy Vitale |
Independent Director |
09/03/2026 |
| Dr. Alfred W. Sandrock, Jr,M.D.,PhD |
Director, President and Chief Executive Officer |
09/03/2026 |
| Dr. Grace E. Colon, PhD |
Independent Director |
09/03/2026 |
| Dr. George A. Scangos,PhD |
Independent Director |
09/03/2026 |
| Dr. Catherine J. Mackey, PhD |
Independent Director |
09/03/2026 |
| Dr. Jude Onyia, PhD |
Director |
09/03/2026 |
|
|
|
|
